Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR) -- Ignore unavailable to you. Want to Upgrade?

To: ajs who wrote (2039)	7/21/1998 10:56:00 AM
From: Machaon	Read Replies (1) \| Respond to of 2553

Well, another nasty day for GENZL. I've got an order in this morning for some more shares. You did well waiting another day before deciding whether or not to buy. What made me decide to try and buy more today was their 33% sequential increase in U.S. Carticel sales, during the 1st qtr, which reflects business conditions mostly in the 3rd and 4th qtr of 1997. To me, that means that their business plan is "starting" to work. But, it's going to take another few quarters of high, sequential growth to significantly bring their burn rate down. I am very worried about the sudden and dramatic drop in stock price. The market is going to make it very painful for long term investors to hang on to their shares. Cross your fingers and hope for a good earnings report tomorrow! Personally, I'm looking for around $4.5 million in total revenues, but am hoping for an upside surprise. Good luck, Bob